Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Ascendis Pharma A/S (ASND)

NASDAQ

$270.62

$-0.45

(-0.17%)

Previous Close: ⁦$271.12⁩

Market Closed

Ascendis Pharma A/S (ASND) Live Price Chart

Last updated: ⁦2026-09-07 17:56:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Ascendis Pharma A/S (ASND) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $270.62, with a market capitalization of $17.75B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $186.05 to $282.15. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$17.75B
Open	$267.96
Day's High	$282.15
Day's Low	$11.92
Previous Close	$271.12
Volume	659.77K
Average Volume	666.22K
P/E Ratio	--
52-Week High	$282.15
52-Week Low	$186.05
Dividend Yield	--
Earnings Date	--

Ascendis Pharma A/S (ASND) Latest Closing Stock Price

Ascendis Pharma A/S (ASND) last closed at $271.12 as of 2026-09-04 23:57:00, unchanged from the previous close of $271.12.

During the latest regular trading session, ASND traded between $11.92 and $282.15, with a volume of 659.77K shares. The closing price was near the upper end and near the upper end of its 52-week range.

Ascendis Pharma A/S (ASND) 7-Day Stock Price Change

Over the past seven days, Ascendis Pharma A/S (ASND) moved from $249.36 to $270.62, representing a gain of 8.53% ($21.26).

The stock traded between $246.30 and $272.44 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 614.59 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ASND 52-Week Price Position

Position in Range: 88.0%

52W Low$186.05

52W High$282.15

ASND is currently trading at $270.62, placing it 88.0% of the way from its 52-week low of $186.05 to its 52-week high of $282.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Ascendis Pharma A/S (ASND)?

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Ascendis Pharma A/S Information

Employees	1189
Exchange	NASDAQ
Company Website	https://www.ascendispharma.com

How to Buy Ascendis Pharma A/S (ASND) Stock on MEXC

Eligible investors can buy real shares of Ascendis Pharma A/S (ASND) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ASND and Place Your Order

Open the RealStocks trading page and search for ASND. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Ascendis Pharma A/S (ASND) stock price today?

Ascendis Pharma A/S (ASND) is currently trading at $ 270.62, down 0.18% ($0.50) from the previous close of $ 271.12. Intraday prices update in real time during regular trading hours.

2.Is ASND stock going up or down today?

As of 2026-09-04 23:57:00, ASND is trading at $ 270.62, down 0.18% ($0.50) from its previous close of $ 271.12. The stock has traded between $ 11.92 and $ 282.15 during today’s regular session. Past price movements do not guarantee future results.

3.What is ASND pre-market price?

As of 2026-09-04 23:57:00, ASND is trading at $ 270.30 in pre-market trading, down 0.30% ($0.82) from the previous close of $ 271.12. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ASND after-hours price?

As of 2026-09-04 23:57:00, ASND is trading at $ 269.50 in after-hours trading, down 0.60% ($1.62) from the regular-session close of $ 271.12. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ASND stock trading now?

ASND trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ASND sit relative to its 52-week high and low?

Over the past 52 weeks, ASND has traded between a low of $ 186.05 and a high of $ 282.15. At $ 270.62, the stock is positioned 88.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Ascendis Pharma A/S in?

Ascendis Pharma A/S (ASND) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Ascendis Pharma A/S's market capitalization and where is it listed?

Ascendis Pharma A/S is listed on the NASDAQ exchange with a market capitalization of $ 17.75B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ASND valued in terms of P/E ratio and EPS?

ASND trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Ascendis Pharma A/S pay a dividend?

Ascendis Pharma A/S pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.